Variation in costs with warfarin, other anticoagulants

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1609, 2007-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenetics of antiplatelets and anticoagulants: a report on clopidogrel, warfarin and dabigatran

By Ross Stephanie   Paré Guillaume  

Pharmacogenomics, Vol. 14, Iss. 13, 2013-10 ,pp. : 1565-1572

Future Medicine

Access to resources Recommend Favorite

Beyond heparin and warfarin: the new generation of anticoagulants

By Weitz Jeffrey I   Linkins Lori-Ann  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 3, 2007-03 ,pp. : 271-282

Informa Healthcare

Access to resources Recommend Favorite

Comparing Direct Oral Anticoagulants and Warfarin for Atrial Fibrillation, Venous Thromboembolism, and Mechanical Heart Valves

By Marcy Todd R.   Truong Teresa   Rai Andrea  

The Consultant Pharmacist, Vol. 30, Iss. 11, 2015-11 ,pp. : 644-656

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

Patient education could reduce warfarin-related bleeding costs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 611, 2010-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

A Policy Model to Evaluate the Benefits, Risks and Costs of Warfarin Pharmacogenomic Testing

By Meckley Lisa M.  

PharmacoEconomics, Vol. 28, Iss. 1, 2010-01 ,pp. : 61-74

Adis International

Access to resources Recommend Favorite